Header Logo

Connection

Matthew Daley to Immunization

Back to Details
This is a "connection" page, showing publications Matthew Daley has written about Immunization.
Matthew Daley
Connection Strength
2.791
Immunization
  1. Quality improvement in immunization delivery following an unsuccessful immunization recall. Ambul Pediatr. 2004 May-Jun; 4(3):217-23.
    View in: PubMed
    Score: 0.226
  2. Vaccination Timeliness Among US Children Aged 0-19 Months, National Immunization Survey-Child 2011-2021. JAMA Netw Open. 2024 Apr 01; 7(4):e246440.
    View in: PubMed
    Score: 0.225
  3. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger - United States, 2024. MMWR Morb Mortal Wkly Rep. 2024 Jan 11; 73(1):6-10.
    View in: PubMed
    Score: 0.221
  4. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older - United States, 2024. MMWR Morb Mortal Wkly Rep. 2024 Jan 11; 73(1):11-15.
    View in: PubMed
    Score: 0.221
  5. The Advisory Committee on Immunization Practices' Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines - United States, 2021. MMWR Morb Mortal Wkly Rep. 2021 Nov 05; 70(44):1545-1552.
    View in: PubMed
    Score: 0.190
  6. Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged =16 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2021. MMWR Morb Mortal Wkly Rep. 2021 Sep 24; 70(38):1344-1348.
    View in: PubMed
    Score: 0.189
  7. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021. MMWR Morb Mortal Wkly Rep. 2021 Aug 13; 70(32):1094-1099.
    View in: PubMed
    Score: 0.187
  8. Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021. MMWR Morb Mortal Wkly Rep. 2021 Jul 09; 70(27):977-982.
    View in: PubMed
    Score: 0.186
  9. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12-15 Years - United States, May 2021. MMWR Morb Mortal Wkly Rep. 2021 May 21; 70(20):749-752.
    View in: PubMed
    Score: 0.184
  10. Patterns of childhood immunization and all-cause mortality. Vaccine. 2017 12 04; 35(48 Pt B):6643-6648.
    View in: PubMed
    Score: 0.144
  11. White Paper on studying the safety of the childhood immunization schedule in the Vaccine Safety Datalink. Vaccine. 2016 Feb 15; 34 Suppl 1:A1-A29.
    View in: PubMed
    Score: 0.128
  12. Effectiveness and cost of immunization recall at school-based health centers. Pediatrics. 2012 Jun; 129(6):e1446-52.
    View in: PubMed
    Score: 0.098
  13. Effectiveness and net cost of reminder/recall for adolescent immunizations. Pediatrics. 2012 Jun; 129(6):e1437-45.
    View in: PubMed
    Score: 0.098
  14. Getting under the hood: exploring issues that affect provider-based recall using an immunization information system. Acad Pediatr. 2011 Jan-Feb; 11(1):44-9.
    View in: PubMed
    Score: 0.090
  15. Identification and recall of children with chronic medical conditions for influenza vaccination. Pediatrics. 2004 Jan; 113(1 Pt 1):e26-33.
    View in: PubMed
    Score: 0.055
  16. Use of Updated COVID-19 Vaccines 2023-2024 Formula for Persons Aged =6 Months: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2023. MMWR Morb Mortal Wkly Rep. 2023 Oct 20; 72(42):1140-1146.
    View in: PubMed
    Score: 0.054
  17. Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines - United States, October 2022. MMWR Morb Mortal Wkly Rep. 2022 Nov 11; 71(45):1436-1441.
    View in: PubMed
    Score: 0.051
  18. Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged =18 years - United States, July 2022. MMWR Morb Mortal Wkly Rep. 2022 Aug 05; 71(31):988-992.
    View in: PubMed
    Score: 0.050
  19. Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months-5 Years - United States, June 2022. MMWR Morb Mortal Wkly Rep. 2022 Jul 01; 71(26):859-868.
    View in: PubMed
    Score: 0.050
  20. Monitoring vaccine safety using the vaccine safety Datalink: Assessing capacity to integrate data from Immunization Information systems. Vaccine. 2022 01 31; 40(5):752-756.
    View in: PubMed
    Score: 0.048
  21. Vaccine timeliness and prevalence of undervaccination patterns in children ages 0-19 months, U.S., National Immunization Survey-Child 2017. Vaccine. 2022 01 31; 40(5):765-773.
    View in: PubMed
    Score: 0.048
  22. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5-11 Years - United States, November 2021. MMWR Morb Mortal Wkly Rep. 2021 Nov 12; 70(45):1579-1583.
    View in: PubMed
    Score: 0.048

© 2024 Kaiser Permanente